Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Japan CHARLOTTE: Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

NCT03229122 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03229122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03229122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Japan CHARLOTTE: Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 26, 2016
Completion date
July 6, 2018
Enrollment
446 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer